Explain how antibiotic resistance could lead to a bacterial disease epidemic

1 answer:

5 0

Antibiotic resistance is such a big, big deal. In fact, the risk of antibiotic resistance is very scary to think about. When we abuse the use of antibiotic for things that aren't really needed to have an antibiotic for or if we don't use them as prescribed or we don't finish the antibiotic, we run this risk of the bacteria becoming resistant. Bacteria are smart. They adapt and overcome, basically like "survival of the fittest".

If we have more or ALL bacteria resistance to antibiotics we start being unable to control bacteria; which can lead to a major epidemic of serious bacteria killing millions of people.

An example is MRSA. MRSA is already a start of an antibiotic resistant bacteria. Now, we typically treat MRSA with Bactrim, Vancomycin, Zosyn. There aren't many but now because the bacteria will adapt and overcome, there is something now called VRSA; which is Vancomycin resistant staph meaning the most potent drug that helps treat MRSA is now resistant. MRSA can kill people without problem.

It's so scary to think about!

You might be interested in

A new drug is developed that prevents the demyelinization occurring in the progress of multiple sclerosis. The drug protects the

Aleonysh [2.5K]

Answer:

Multiple sclerosis (MS) is the most common demyelinating and an autoimmune disease of the central nervous system characterized by immune-mediated myelin and axonal damage, and chronic axonal loss attributable to the absence of myelin sheaths. T cell subsets (Th1, Th2, Th17, CD8+, NKT, CD4+CD25+ T regulatory cells) and B cells are involved in this disorder, thus new MS therapies seek damage prevention by resetting multiple components of the immune system. The currently approved therapies are immunoregulatory and reduce the number and rate of lesion formation but are only partially effective. This review summarizes current understanding of the processes at issue: myelination, demyelination and remyelination—with emphasis upon myelin composition/architecture and oligodendrocyte maturation and differentiation. The translational options target oligodendrocyte protection and myelin repair in animal models and assess their relevance in human. Remyelination may be enhanced by signals that promote myelin formation and repair. The crucial question of why remyelination fails is approached is several ways by examining the role in remyelination of available MS medications and avenues being actively pursued to promote remyelination including: (i) cytokine-based immune-intervention (targeting calpain inhibition), (ii) antigen-based immunomodulation (targeting glycolipid-reactive iNKT cells and sphingoid mediated inflammation) and (iii) recombinant monoclonal antibodies-induced remyelination.Keywords: calpain, central nervous system, demyelination, fingolimod, glycolipids, lipids, multiple sclerosis, myelin, myelination, NKT cells, oligodendrocytes, remyelination, T cells

Explanation:

5 0

2 years ago

A nurse remembers bronchiolitis mainly occurs in children under the age of

Vlada [557]

Under the age of 6. You are welcome.

8 0

3 years ago

zheka24 [161]

Answer:

10-35%

Explanation: